Komori
Oiles (6282) · RiskRestated

Accidents, Recalls and Customer Production Stoppages Caused by Quality Nonconformities

First written in FY2017. 12 of 15 entries say "Restated". Latest entry: FY2024.

15entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY2022-Q2MitigatedFY2022 – FY20232017: 120172018: 220182019: 320192020: 320202021: 320212022: 120222023: 120232024: 12024
Same theme, other companies
Risk of product recalls and regulatory action due to serious quality issuesA theme 91 companies write about · 92 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 13 of 35 companies on the "Worse" side.

49 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 91 companies compared. The sentences above are computed from all 91.
Full recordFilings, disclosures and news, newest first
  1. FY2024RestatedAnnual report

    「To establish quality assurance systems that meet the requirements of all customers and markets, the Group's domestic and overseas businesses have obtained international quality management standards certifications (ISO9001 or IATF16949).」

    The company continues to describe its quality assurance system based on ISO9001 or IATF16949, design reviews and other measures, together with the risk of quality nonconformity.
  2. FY2023MitigatedAnnual report

    「To establish quality assurance systems that meet the requirements of all customers and markets, the Group's domestic and overseas businesses have obtained international quality management standards certifications (ISO9001 or IATF16949).」

    As measures addressing the risk of quality nonconformity, the company specifies a quality assurance system including ISO9001 or IATF16949 certification, design reviews and product liability insurance.
  3. FY2022MitigatedAnnual report

    「In product development, the Group has adopted a method under which departments including research and development, production engineering, manufacturing and sales identify quality issues from their respective perspectives at the initial stage and resolve them using information on past quality problems inside and outside the Group. Even before a product is launched as a new product, the Group verifies quality through design reviews of the product and production-process designs and seeks to minimize risks.」

    In addition to quality assurance systems such as ISO, the company specifies the identification of quality issues from the early development stage and design reviews, making its response to the risk of quality nonconformity more concrete.
  4. FY2022-Q2RestatedAnnual report

    「No new business or other risks arose during the six-month cumulative period under review. There were also no material changes to the business and other risks described in the annual securities report for the previous consolidated fiscal year.」

    The company states that there have been no material changes in the risks of accidents and recalls resulting from quality nonconformity.
  5. FY2022-Q1RestatedAnnual report

    「No new business or other risks arose during the cumulative first quarter of the current consolidated fiscal year. There were also no significant changes to the business or other risks described in the securities report for the previous consolidated fiscal year.」

    The company states that there have been no material changes in the risks of accidents and recalls resulting from quality nonconformity.
  6. FY2021-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter, and there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes in the risks of accidents and recalls resulting from quality nonconformity.
  7. FY2021-Q2RestatedAnnual report

    「No new business or other risks arose during the six-month cumulative period under review. There were also no material changes to the business and other risks described in the annual securities report for the previous consolidated fiscal year.」

    The company states that there have been no material changes in the risks of accidents and recalls resulting from quality nonconformity.
  8. FY2021-Q1RestatedAnnual report

    「No new business or other risks arose during the cumulative first quarter of the current consolidated fiscal year. There were also no significant changes to the business or other risks described in the securities report for the previous consolidated fiscal year.」

    The company states that there have been no material changes in the risks of accidents and recalls resulting from quality nonconformity.
  9. FY2020-Q3RestatedAnnual report

    「There have been no material changes in the business and other risks described in the securities report for the previous consolidated fiscal year.」

    The company states that there have been no material changes in the risks of accidents and recalls resulting from quality nonconformity.
  10. FY2020-Q1RestatedAnnual report

    「There have been no material changes in the business and other risks described in the securities report for the previous consolidated fiscal year.」

    The company states that there have been no material changes in the risks of accidents and recalls resulting from quality nonconformity.
  11. FY2019RestatedAnnual report

    「In consideration of the above, the Group has established a quality assurance system designed to meet the requirements of all markets. However, if a product contains a serious undetected defect and this leads to an accident, recall or customer production stoppage due to nonconformity, the Group may incur substantial costs and suffer a decline in social credibility. In addition, if the Group's contractual share of product warranty costs increases, its operating performance and financial position may be adversely affected.」

    While maintaining a quality assurance system, the company continues to identify risks related to serious defects, accidents, recalls and customer production stoppages.
  12. FY2019-Q3RestatedAnnual report

    「There have been no material changes in the business and other risks described in the securities report for the previous consolidated fiscal year.」

    The company states that there have been no material changes in the risks of accidents and recalls resulting from quality nonconformity.
  13. FY2019-Q2RestatedAnnual report

    「No new business or other risks arose during the six-month cumulative period under review. There were also no material changes to the business and other risks described in the annual securities report for the previous consolidated fiscal year.」

    The company states that there have been no material changes in the risks of accidents and recalls resulting from quality nonconformity.
  14. FY2018RestatedAnnual report

    「In consideration of the above, the Group has established a quality assurance system designed to meet the requirements of all markets. However, if a product contains a serious undetected defect and this leads to an accident, recall or customer production stoppage due to nonconformity, the Group may incur substantial costs and suffer a decline in social credibility. In addition, if the Group's contractual share of product warranty costs increases, its operating performance and financial position may be adversely affected.」

    While presenting the establishment of a quality assurance system as a countermeasure, the company continues to identify risks related to serious defects, accidents and recalls.
  15. FY2017First statedAnnual report

    「If a product contains a serious undetected defect and this leads to an accident, recall or customer production stoppage due to nonconformity, the Group may incur substantial costs and suffer a decline in social credibility. In addition, if the Group's contractual share of product warranty costs increases, its operating performance and financial position may be adversely affected.」

    The company describes the risk of quality nonconformity associated with supplying products for a broad range of applications, including automobiles, social infrastructure, buildings and housing, as well as measures involving its quality assurance system and product liability insurance.
Moved together

"Deepening penetration in the general industrial sector and global expansion in the automotive sector" moved the same way as this thread, in the same document, in 2 of its 15 moves.

22222★12345
  1. ★This thread
  2. 1Deepening penetration in the general industrial sector and global expansion in the automotive sector2×
  3. 2Share repurchases aimed at enhancing shareholder value and improving capital efficiency2×
  4. 3Group-Wide Internal Control, Compliance and Risk Management Framework2×
  5. 4Reviewing the Rationale for Strategic Shareholdings and Reducing Holdings with Limited Strategic Significance2×
  6. 5Grant of Restricted Stock through an Employee Stock Ownership Association2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Oiles's next results are scheduled for 2026-11-06. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Accidents, Recalls and Customer Production Stoppages Caused by Quality Nonconformities | OILES CORPORATION (6282) | Komori